Back to List View Graph View

Breast cancer

Breast cancer is a heterogeneous malignant disease arising from breast tissue, most commonly from the epithelial cells of the ducts or lobules.

Where the papers sit

26 papers from the last 6 months study breast cancer directly · updated from PubMed 15 Nov 2026

Study type 0 clinical trials · 8 observational · 12 human data · 5 preclinical · 1 unclassified

Themes one subject · 1 new direction

Those 26 are all about one subject.

  • Breast Cancer Care and Outcomes

    Diagnosis, treatment, prevention, and survivorship remain the shared focus, spanning molecular risk markers, cardiometabolic complications, and supportive care. Automated CT biomarkers, cell-free DNA, ctDNA, senescence signatures, and multi-omics aim to improve risk assessment or response monitoring. Clinical outcomes recur alongside disparities in access, ageism, mental health, Covid-19 disruption, and cardiovascular mortality. Preventive mRNA-LNP vaccination and inavolisib-based combinations extend the work toward earlier intervention, but no single therapeutic direction unifies the cluster.

    26 papers

NEW DIRECTION

Breast cancer becomes a preventable target through vaccination against its putative cell of origin

The prophylactic Lalba mRNA-LNP vaccination study in carcinogen-exposed Sprague-Dawley rats treats mammary tumorigenesis as something that can be intercepted before cancer develops, rather than as an established disease to diagnose, treat, monitor, or support after diagnosis; vaccination induced LALBA-specific immune responses, suppressed mammary tumorigenesis, and improved tumor-free and overall survival without obvious toxicity in normal tissues 42685084Sep. This gives breast cancer a prevention role outside the set’s diagnostic, therapeutic, prognostic, survivorship, and care-delivery roles by targeting a putative normal mammary cell of origin before malignant disease emerges.

Papers

The 26 papers from the last 6 months that study breast cancer directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Breast Cancer Care and Outcomes (26)
  1. Computed tomography derived cardiometabolic biomarkers in high-risk breast cancer using fully automated deep learning algorithms. Breast cancer research and treatment · 14 Nov 2026 PMID 43033331
  2. Clinicopathological differences between asymptomatic vs symptomatic breast cancer: a 30-year single-center retrospective study. Breast cancer research and treatment · 4 Nov 2026 PMID 42980748
  3. Regional differences in cancer treatment among American Indian and Alaska native peoples: a surveillance, epidemiology, and end results study. Cancer causes & control : CCC · 3 Nov 2026 PMID 42975705
  4. Gendered ageism among women undergoing mastectomy across two life stages: early adulthood and later life in Pakistan. International journal for equity in health · 23 Oct 2026 PMID 42920130
  5. A Senescence-Related Signature for Risk Stratification and Predicted Immunotherapy Response in Breast Cancer: Integrative Pathology and Multi-Omics Analysis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 23 Oct 2026 PMID 42910514
  6. Mental health status and associated factors among Chinese postoperative breast cancer survivors of working age: a cross-sectional study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 16 Oct 2026 PMID 42886293
  7. Impact of and recovery after Covid-19 on breast cancer diagnosis and care in Johannesburg, South Africa. BMC cancer · 3 Oct 2026 PMID 42829437
  8. Mastectomy and sentinel lymph node biopsy in a patient with left-sided breast cancer and Poland syndrome. BMJ case reports · 1 Oct 2026 PMID 42823144
  9. Serial ctDNA Analysis for Monitoring Molecular Response and Acquired Resistance in Metastatic NSCLC and HR+/HER2-Negative Breast Cancer: A Real-World Study. Cancer medicine · 1 Oct 2026 PMID 42817873
  10. Cardiovascular events and mortality after breast cancer diagnosis: multistate models in a nationwide cohort study. BMJ open · 23 Sept 2026 PMID 42778238
  11. Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell genomics · 21 Sept 2026 PMID 42767223
  12. Supportive care needs among patients with breast and cervical cancer at a tertiary cancer treatment center in ethiopia: a cross-sectional study. Scientific reports · 3 Sept 2026 PMID 42686973
  13. Breast cancer prevention by prophylactic Lalba mRNA-LNP vaccination. Proceedings of the National Academy of Sciences of the United States of America · 2 Sept 2026 PMID 42685084
  14. Acceptability, perceived outcomes and underlying mechanisms of a professionally led support group intervention for women with breast cancer using a qualitative method approach. British journal of health psychology · 29 Aug 2026 PMID 42665917
  15. Integrated multi-omics, machine learning, network toxicology, and molecular docking reveal potential mechanisms underlying methyl 4-hydroxybenzoate-associated breast cancer. Molecular diversity · 28 Aug 2026 PMID 42665765
  16. The Phosphatidylinositol 3-Kinase (PI3K) Inhibitor Inavolisib Has Breast-cancer Synergy Combined With Recombinant Methioninase But Not on Normal Cells. In vivo (Athens, Greece) · 28 Aug 2026 PMID 42665384
  17. The Brazilian breast cancer patient navigation program: impact on waiting times and treatment costs. Health policy and planning · 18 Aug 2026 PMID 42609103
  18. Glycoconjugate strategy for GLUT-driven curcumin delivery and anticancer activity in breast cancer cells. Scientific reports · 14 Aug 2026 PMID 42601367
  19. Impact of Metformin Use on Clinical and Pathological Outcomes in Breast Cancer Patients With Type 2 Diabetes. Cancer reports (Hoboken, N.J.) · 30 Jul 2026 PMID 42528302
  20. HSimGCDA: A novel higher-order similarity graph representation learning method for identifying CircRNA-disease associations. Bioorganic chemistry · 29 Jul 2026 PMID 42526132
  21. Pattern of opioid prescriptions among patients with breast, lung, and colorectal cancer diagnosed with pre-existing chronic non-cancer pain. PloS one · 29 Jul 2026 PMID 42525681
  22. A prognostic risk model based on programmed cell death genes for breast cancer and its potential clinical application. Medicine · 25 Jul 2026 PMID 42499036
  23. PathMED: an R toolkit for single-sample molecular scoring and machine learning with omics data. Bioinformatics (Oxford, England) · 24 Jul 2026 PMID 42496598
  24. A Mitochondria-Targeted Iridium(III) Complex as a Potent Type-I/II Photosensitizer for Pyroptosis-Based Breast Cancer Therapy. Journal of medicinal chemistry · 23 Jul 2026 PMID 42489638
  25. An advanced AI-driven deep learning framework for early detection and precise diagnosis of breast cancer from medical images. Computers in biology and medicine · 13 Jul 2026 PMID 42442269
  26. Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast Cancer. Cancer research · 10 Jun 2026 PMID 42268298

By study type

Observational studies and case reports (8)
  1. Clinicopathological differences between asymptomatic vs symptomatic breast cancer: a 30-year single-center retrospective study. Breast cancer research and treatment · 4 Nov 2026 PMID 42980748
  2. Mental health status and associated factors among Chinese postoperative breast cancer survivors of working age: a cross-sectional study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 16 Oct 2026 PMID 42886293
  3. Mastectomy and sentinel lymph node biopsy in a patient with left-sided breast cancer and Poland syndrome. BMJ case reports · 1 Oct 2026 PMID 42823144
  4. Serial ctDNA Analysis for Monitoring Molecular Response and Acquired Resistance in Metastatic NSCLC and HR+/HER2-Negative Breast Cancer: A Real-World Study. Cancer medicine · 1 Oct 2026 PMID 42817873
  5. Cardiovascular events and mortality after breast cancer diagnosis: multistate models in a nationwide cohort study. BMJ open · 23 Sept 2026 PMID 42778238
  6. Supportive care needs among patients with breast and cervical cancer at a tertiary cancer treatment center in ethiopia: a cross-sectional study. Scientific reports · 3 Sept 2026 PMID 42686973
  7. Impact of Metformin Use on Clinical and Pathological Outcomes in Breast Cancer Patients With Type 2 Diabetes. Cancer reports (Hoboken, N.J.) · 30 Jul 2026 PMID 42528302
  8. Pattern of opioid prescriptions among patients with breast, lung, and colorectal cancer diagnosed with pre-existing chronic non-cancer pain. PloS one · 29 Jul 2026 PMID 42525681
Human data, design not indexed (12)
  1. Computed tomography derived cardiometabolic biomarkers in high-risk breast cancer using fully automated deep learning algorithms. Breast cancer research and treatment · 14 Nov 2026 PMID 43033331
  2. Regional differences in cancer treatment among American Indian and Alaska native peoples: a surveillance, epidemiology, and end results study. Cancer causes & control : CCC · 3 Nov 2026 PMID 42975705
  3. Gendered ageism among women undergoing mastectomy across two life stages: early adulthood and later life in Pakistan. International journal for equity in health · 23 Oct 2026 PMID 42920130
  4. Impact of and recovery after Covid-19 on breast cancer diagnosis and care in Johannesburg, South Africa. BMC cancer · 3 Oct 2026 PMID 42829437
  5. Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell genomics · 21 Sept 2026 PMID 42767223
  6. Acceptability, perceived outcomes and underlying mechanisms of a professionally led support group intervention for women with breast cancer using a qualitative method approach. British journal of health psychology · 29 Aug 2026 PMID 42665917
  7. The Brazilian breast cancer patient navigation program: impact on waiting times and treatment costs. Health policy and planning · 18 Aug 2026 PMID 42609103
  8. HSimGCDA: A novel higher-order similarity graph representation learning method for identifying CircRNA-disease associations. Bioorganic chemistry · 29 Jul 2026 PMID 42526132
  9. A prognostic risk model based on programmed cell death genes for breast cancer and its potential clinical application. Medicine · 25 Jul 2026 PMID 42499036
  10. PathMED: an R toolkit for single-sample molecular scoring and machine learning with omics data. Bioinformatics (Oxford, England) · 24 Jul 2026 PMID 42496598
  11. An advanced AI-driven deep learning framework for early detection and precise diagnosis of breast cancer from medical images. Computers in biology and medicine · 13 Jul 2026 PMID 42442269
  12. Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast Cancer. Cancer research · 10 Jun 2026 PMID 42268298
Preclinical: animal, cell and lab studies (5)
  1. A Senescence-Related Signature for Risk Stratification and Predicted Immunotherapy Response in Breast Cancer: Integrative Pathology and Multi-Omics Analysis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 23 Oct 2026 PMID 42910514
  2. Breast cancer prevention by prophylactic Lalba mRNA-LNP vaccination. Proceedings of the National Academy of Sciences of the United States of America · 2 Sept 2026 PMID 42685084
  3. The Phosphatidylinositol 3-Kinase (PI3K) Inhibitor Inavolisib Has Breast-cancer Synergy Combined With Recombinant Methioninase But Not on Normal Cells. In vivo (Athens, Greece) · 28 Aug 2026 PMID 42665384
  4. Glycoconjugate strategy for GLUT-driven curcumin delivery and anticancer activity in breast cancer cells. Scientific reports · 14 Aug 2026 PMID 42601367
  5. A Mitochondria-Targeted Iridium(III) Complex as a Potent Type-I/II Photosensitizer for Pyroptosis-Based Breast Cancer Therapy. Journal of medicinal chemistry · 23 Jul 2026 PMID 42489638
Unclassified: not yet indexed with MeSH (1)
  1. Integrated multi-omics, machine learning, network toxicology, and molecular docking reveal potential mechanisms underlying methyl 4-hydroxybenzoate-associated breast cancer. Molecular diversity · 28 Aug 2026 PMID 42665765